Lipid & Cholesterol Panel

A cardiovascular risk panel measuring total cholesterol, HDL (protective), LDL (atherogenic), non-HDL cholesterol, triglycerides, and cholesterol ratios. Goes beyond a simple total cholesterol number to assess the lipoprotein patterns that actually predict heart disease risk — the ratio of HDL to total cholesterol and triglyceride-to-HDL ratio are stronger predictors than LDL alone.

Cardiovascular disease remains the leading cause of death in Australia, and the lipid profile is the foundation of cardiovascular risk assessment. This panel goes beyond a simple total cholesterol number to measure the lipoprotein subfractions and ratios that actually predict heart disease risk — because the relationship between cholesterol and cardiovascular events is more nuanced than total cholesterol alone suggests. The panel measures total cholesterol, HDL cholesterol (the protective fraction that transports cholesterol away from arteries), LDL cholesterol (the atherogenic fraction that deposits cholesterol in arterial walls), non-HDL cholesterol (a comprehensive measure of all atherogenic particles), triglycerides, and calculated ratios. The triglyceride-to-HDL ratio and total cholesterol-to-HDL ratio are increasingly recognised as stronger predictors of cardiovascular risk than LDL alone. Context matters for interpretation. LDL cholesterol can be normal while the number of LDL particles is elevated (discordance), and small dense LDL particles are more atherogenic than large buoyant ones. Triglycerides above 1.7 mmol/L combined with low HDL often indicate insulin resistance — a metabolic pattern that drives cardiovascular risk independently of LDL. This is why ClearLabs recommends pairing the lipid panel with metabolic markers (HbA1c, fasting insulin) for a complete cardiovascular picture. An 8-12 hour fast is required for accurate triglyceride measurement. ClearLabs delivers results within 2-3 business days, displayed against both conventional and optimal ranges on the digital dashboard. For those on statin therapy or making dietary changes, serial testing every 3-6 months tracks the impact of interventions on lipid patterns.